Matrix regenerative therapy

Rom J Ophthalmol. 2017 Jan-Mar;61(1):2-10. doi: 10.22336/rjo.2017.2.

Abstract

The extracellular matrix (ECM) is responsible for many of the cell behavior processes, including cell proliferation and growth, survival, change in cell shape, migration, and differentiation. The most important component of the ECM is heparan sulfate (HS), because it insures the storage of many cell communication proteins, necessary for the continuous and identical renewal of cells and thus for tissue regeneration. Regenerating agents (RGTA®) are bioengineered structural analogues of heparan sulfate glycosaminoglycans that replace the degraded endogenous HS of the ECM. In the ophthalmological field, RGTA® represents an innovative approach for the improvement of the ocular surface wound healing and matrix remodeling and plays a role in controlling and regulating the wound healing process in various ocular diseases.

Keywords: RGTA; extracellular matrix; regenerating agents; wound healing.

Publication types

  • Review

MeSH terms

  • Biomimetic Materials / chemistry
  • Biomimetic Materials / therapeutic use*
  • Cell- and Tissue-Based Therapy / methods*
  • Corneal Diseases / metabolism
  • Corneal Diseases / therapy*
  • Extracellular Matrix / metabolism*
  • Guided Tissue Regeneration / methods
  • Heparitin Sulfate / chemistry
  • Heparitin Sulfate / therapeutic use*
  • Humans
  • Regenerative Medicine / methods
  • Tissue Engineering / methods
  • Wound Healing / physiology*

Substances

  • Heparitin Sulfate